Trestle Bio Partners with Humacyte to Advance Bioengineered Kidney Research Trestle Biotherapeutics, Inc., a company dedicated to developing bioengineered kidney tissues for patients with end-stage renal disease (ESRD), has announced a significant research collaboration with Humacyte, Inc. Humacyte, a commercial-stage…
Aerospace & Life Sciences Testing, Inspection, and Certification Market Overview has been added to ResearchAndMarkets.com’s offering. The global market for Aerospace & Life Sciences Testing, Inspection, and Certification (TIC) services is expected to grow significantly in the coming years. Valued at approximately…
Draslovka Partners with Natron Energy to Advance Sodium-Ion Battery Production Introduction to the Partnership Draslovka a.s., a global leader in sustainability-driven technologies, reagents, and services for the mining and energy transition sectors, has entered into a strategic partnership with Natron…
QIAGEN Receives U.S. FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel QIAGEN has announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B, marking a significant milestone in the company’s…
ENCell’s EN001 Receives FDA Orphan Drug Designation for Charcot-Marie-Tooth Disease ENCell, a leading biopharmaceutical company specializing in cell and gene therapy, has announced that its investigational drug, EN001, has been granted Orphan Drug Designation (ODD) by the U.S. Food and…
Colorado BioScience Association Welcomes Four New Leaders to Board of Directors The Colorado BioScience Association has announced the appointment of four new accomplished leaders to its Board of Directors, a move that further strengthens the organization’s efforts to enhance it’s…
Promega Sues Aobious for Patent Infringement Over Furimazine Substrates Promega Corporation, a global leader in biotechnology tools, announced that it has filed a patent infringement lawsuit against Aobious, Inc. The lawsuit, filed in the U.S. District Court for the District…
TRIMTECH Therapeutics Secures $31M in Seed Funding to Advance Targeted Protein Degradation Treatments for Neurodegenerative Diseases TRIMTECH Therapeutics, a biotech company focused on developing therapies using targeted protein degradation (TPD) for neurodegenerative diseases, has announced the successful completion of its…
Atwell Gives Foundation Partners with Science Olympiad to Expand STEM Opportunities The Atwell Gives Foundation has launched a new national partnership with Science Olympiad, one of the largest and most well-known STEM (science, technology, engineering, and math) team competitions in…
DAFFODIL™ Study Results Highlight Long-Term Safety and Efficacy of DAYBUE® (Trofinetide) in Younger Patients with Rett Syndrome Acadia Pharmaceuticals Inc. has announced the publication of results from the open-label DAFFODIL™ study in the journal Med. The study evaluated the long-term…
Supreme Group Acquires Kadiko to Strengthen Digital and Creative Capabilities in Healthcare and Life Sciences Supreme Group, a leading platform focused on driving innovation in healthcare and life sciences marketing and communications, has announced the acquisition of Kadiko, a digital-first…
Elegen Reduces Pricing for ENFINIA™ DNA, Expanding Access to Advanced Cell-Free DNA Manufacturing Elegen, a leader in next-generation cell-free DNA manufacturing, has announced a 25% reduction in the pricing of its ENFINIA™ DNA products. This move makes high-quality, long, complex,…